Cargando…
Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit
INTRODUCTION: Heparin is safe and prevents venous thromboembolism in critical illness. We aimed to determine the guideline concordance for thromboprophylaxis in critically ill patients and its predictors, and to analyze factors associated with the use of low molecular weight heparin (LMWH), as it ma...
Autores principales: | Lauzier, François, Muscedere, John, Deland, Éric, Kutsogiannis, Demetrios Jim, Jacka, Michael, Heels-Ansdell, Diane, Crowther, Mark, Cartin-Ceba, Rodrigo, Cox, Michael J, Zytaruk, Nicole, Foster, Denise, Sinuff, Tasnim, Clarke, France, Thompson, Patrica, Hanna, Steven, Cook, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057024/ https://www.ncbi.nlm.nih.gov/pubmed/24766968 http://dx.doi.org/10.1186/cc13844 |
Ejemplares similares
-
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
por: Cook, Deborah, et al.
Publicado: (2008) -
Antiembolic stockings and pneumatic compression devices in a medical-surgical thromboprophylaxis trial
por: Zytaruk, N, et al.
Publicado: (2011) -
Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT
por: Johnstone, Jennie, et al.
Publicado: (2019) -
In medical-surgical ICU patients, major bleeding is common but independent of heparin prophylaxis
por: Lauzier, F, et al.
Publicado: (2012) -
Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial
por: Pai, Menaka, et al.
Publicado: (2018)